Literature DB >> 11053213

5-HT(4) receptors on cholinergic nerves involved in contractility of canine and human large intestine longitudinal muscle.

N H Prins1, L M Akkermans, R A Lefebvre, J A Schuurkes.   

Abstract

5-HT(4) receptors mediate circular muscle relaxation in both human and canine large intestine, but this phenomenon alone can not explain the improvement in colonic motility induced by selective 5-HT(4) receptor agonists in vivo. We set out to characterize 5-HT(4) receptor-mediated effects in longitudinal muscle strips of canine and human large intestine. Electrical field stimulation (EFS) was applied providing submaximal isotonic contractions. L-NOARG (0.1 mM) was continuously present in the organ bath to preclude nitric oxide-induced relaxation to EFS. The selective 5-HT(4) receptor agonist prucalopride (0.3 microM) enhanced EFS-evoked contractions, that were antagonized in both preparations by the selective 5-HT(4) receptor antagonist GR 113808 (0.1 microM). The prucalopride-induced increase was present in canine ascending and descending colon, but absent in rectum. Regional differences in response to prucalopride were not observed in human ascending and sigmoid colon and rectum. Incubation with atropine (1 microM) or tetrodotoxin (0.3 microM) inhibited EFS-induced contractions, which were then unaffected by prucalopride (0.3 microM) in both tissues. In the presence of methysergide (3 microM; both tissues) and granisetron (0.3 microM; only human tissues), 5-HT (0.3 microM) enhanced EFS-induced contractions, an effect that was antagonized by GR 113808 (0.1 microM). In the presence of atropine or tetrodotoxin, EFS-induced contractions were inhibited, leaving 5-HT (0.3 microM) ineffective in both preparations. This study demonstrates for the first time that in human and canine large intestine, 5-HT(4) receptors are located on cholinergic neurones, presumably mediating facilitating release of acetylcholine, resulting in enhanced longitudinal muscle contractility. This study and previous circular muscle strip studies suggest that 5-HT(4) receptor agonism facilitates colonic propulsion via a coordinated combination of inhibition of circumferential resistance and enhancement of longitudinal muscle contractility.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11053213      PMCID: PMC1572403          DOI: 10.1038/sj.bjp.0703615

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  25 in total

1.  A comparative study of functional 5-HT4 receptors in human colon, rat oesophagus and rat ileum.

Authors:  P G McLean; I M Coupar; P Molenaar
Journal:  Br J Pharmacol       Date:  1995-05       Impact factor: 8.739

2.  5-HT3 and 5-HT4 receptors and cholinergic and tachykininergic neurotransmission in the guinea-pig proximal colon.

Authors:  M R Briejer; J A Schuurkes
Journal:  Eur J Pharmacol       Date:  1996-07-18       Impact factor: 4.432

3.  5-HT4 receptors in rat but not guinea pig, rabbit or dog esophageal smooth muscle.

Authors:  M L Cohen; A D Susemichel; W Bloomquist; D W Robertson
Journal:  Gen Pharmacol       Date:  1994-10

4.  Blockade of human atrial 5-HT4 receptors by GR 113808.

Authors:  A J Kaumann
Journal:  Br J Pharmacol       Date:  1993-11       Impact factor: 8.739

5.  Stimulant effects of 5-hydroxytryptamine on guinea pig stomach preparations in vitro.

Authors:  K H Buchheit; T Buhl
Journal:  Eur J Pharmacol       Date:  1994-09-01       Impact factor: 4.432

6.  GR113808: a novel, selective antagonist with high affinity at the 5-HT4 receptor.

Authors:  J D Gale; C J Grossman; J W Whitehead; A W Oxford; K T Bunce; P P Humphrey
Journal:  Br J Pharmacol       Date:  1994-01       Impact factor: 8.739

7.  Antagonism by SB 204070 of 5-HT-evoked contractions in the dog stomach: an in-vivo model of 5-HT4 receptor function.

Authors:  S Bingham; B F King; B Rushant; M I Smith; L Gaster; G J Sanger
Journal:  J Pharm Pharmacol       Date:  1995-03       Impact factor: 3.765

8.  5-Hydroxytryptamine (5-HT)4 receptors in post mortem human brain tissue: distribution, pharmacology and effects of neurodegenerative diseases.

Authors:  G P Reynolds; S L Mason; A Meldrum; S De Keczer; H Parnes; R M Eglen; E H Wong
Journal:  Br J Pharmacol       Date:  1995-03       Impact factor: 8.739

9.  Coexpression of 5-HT2A and 5-HT4 receptors coupled to distinct signaling pathways in human intestinal muscle cells.

Authors:  J F Kuemmerle; K S Murthy; J R Grider; D C Martin; G M Makhlouf
Journal:  Gastroenterology       Date:  1995-12       Impact factor: 22.682

10.  The 5-HT4 receptor: molecular cloning and pharmacological characterization of two splice variants.

Authors:  C Gerald; N Adham; H T Kao; M A Olsen; T M Laz; L E Schechter; J A Bard; P J Vaysse; P R Hartig; T A Branchek
Journal:  EMBO J       Date:  1995-06-15       Impact factor: 11.598

View more
  25 in total

1.  Selective desensitization of the 5-HT4 receptor-mediated response in pig atrium but not in stomach.

Authors:  J H De Maeyer; J A J Schuurkes; R A Lefebvre
Journal:  Br J Pharmacol       Date:  2009-01-13       Impact factor: 8.739

2.  The effects of daikenchuto (DKT) on propulsive motility in the colon.

Authors:  Michael J Wood; Neil H Hyman; Gary M Mawe
Journal:  J Surg Res       Date:  2009-05-03       Impact factor: 2.192

Review 3.  Irritable bowel syndrome: new agents targeting serotonin receptor subtypes.

Authors:  F De Ponti; M Tonini
Journal:  Drugs       Date:  2001       Impact factor: 9.546

4.  Effects of 5-HT2B, 5-HT3 and 5-HT4 receptor antagonists on gastrointestinal motor activity in dogs.

Authors:  Hiroki Morita; Erito Mochiki; Nobuyuki Takahashi; Kiyoshi Kawamura; Akira Watanabe; Toshinaga Sutou; Atsushi Ogawa; Mitsuhiro Yanai; Kyoichi Ogata; Takaaki Fujii; Tetsuro Ohno; Souichi Tsutsumi; Takayuki Asao; Hiroyuki Kuwano
Journal:  World J Gastroenterol       Date:  2013-10-21       Impact factor: 5.742

5.  A comparison of the pharmacological properties of guinea-pig and human recombinant 5-HT4 receptors.

Authors:  R G Vickery; N Mai; E Kaufman; D T Beattie; T Pulido-Rios; M O'Keefe; P P A Humphrey; J A M Smith
Journal:  Br J Pharmacol       Date:  2007-02-12       Impact factor: 8.739

6.  Therapeutic advances in functional gastrointestinal disease: irritable bowel syndrome.

Authors:  Alexandru Gaman; Maria Cristina Bucur; Braden Kuo
Journal:  Therap Adv Gastroenterol       Date:  2009-05-01       Impact factor: 4.409

Review 7.  Prucalopride: a review of its use in the management of chronic constipation.

Authors:  Gillian M Keating
Journal:  Drugs       Date:  2013-11       Impact factor: 9.546

8.  Pharmacology and metabolism of renzapride : a novel therapeutic agent for the potential treatment of irritable bowel syndrome.

Authors:  Nicholas L Meyers; Roger I Hickling
Journal:  Drugs R D       Date:  2008

9.  Anti-diarrheal activity and toxicity of Learng Pid Samud recipe.

Authors:  Seewaboon Sireeratawong; Parirat Khonsung; Urarat Nanna; Supaporn Vannasiri; Nirush Lertprasertsuke; Tipaya Singhalak; Noppamas Soonthornchareonnon; Kanjana Jaijoy
Journal:  Afr J Tradit Complement Altern Med       Date:  2012-07-01

10.  Predominant mucosal expression of 5-HT₄(+h) receptor splice variants in pig stomach and colon.

Authors:  Evelien K V Priem; Joris H De Maeyer; Mado Vandewoestyne; Dieter Deforce; Romain A Lefebvre
Journal:  World J Gastroenterol       Date:  2013-06-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.